Disseminated Brucella melitensis infection following canakinumab treatment

Travel Med Infect Dis. 2022 Jan-Feb:45:102227. doi: 10.1016/j.tmaid.2021.102227. Epub 2021 Nov 29.

Authors

Hakan Oral¹, Meliha Çağla Sönmezer², Adalet Elçin Yıldız³, Gülşen Hazırolan⁴, Gökhan Metan², Ahmet Çağkan İnkaya⁵

Affiliations

¹ Hacettepe University, Department of Internal Medicine, Ankara, Turkey.
² Hacettepe University, Department of Infectious Diseases and Clinical Microbiology, Ankara, Turkey.
³ Hacettepe University, Department of Radiology, Ankara, Turkey.
⁴ Hacettepe University, Department of Microbiology, Ankara, Turkey.
⁵ Hacettepe University, Department of Infectious Diseases and Clinical Microbiology, Ankara, Turkey. Electronic address: inkayaac@yahoo.com.

PMID: 34856407
DOI: 10.1016/j.tmaid.2021.102227

No abstract available

Keywords: Brucella; Discitis; Endocarditis; Interleukin-1 beta.

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Humanized / adverse effects
Brucella melitensis*
Brucellosis* / drug therapy
Humans

Substances

Antibodies, Monoclonal, Humanized
canakinumab